--- title: "Logic Model and Impact Evaluation Methodology" ocid: "ocds-h6vhtk-02c149" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02c149" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-02c149.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-02c149.json" source: "Find A Tender Service" current_stage: "Tender" buyer: "MEDICINES DISCOVERY CATAPULT" published: "2021-06-29" --- # Logic Model and Impact Evaluation Methodology Buyer: MEDICINES DISCOVERY CATAPULT Current stage: Tender OCID: ocds-h6vhtk-02c149 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02c149) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-02c149.json) ## Summary The Medicines Discovery Catapult is seeking proposals for a project titled "Logic Model and Impact Evaluation Methodology," which falls under the business services industry, specifically related to law, marketing, consulting, recruitment, printing, and security. This active tender is at the planning stage, with a bid submission deadline of 9 July 2021, and it is anticipated to have a contract period ending on 31 October 2021. The estimated value ranges from £20,000 to £35,000. The procurement is being conducted through an open procedure, allowing participation from various suppliers. This tender presents a significant opportunity for businesses involved in research, drug discovery, and health-related services, particularly those with expertise in developing evaluation methodologies or logic models. Companies that align with the Medicines Discovery Catapult's objective of advancing innovative drug discovery approaches, such as SMEs, consultancy firms, and technology providers, could leverage this project to expand their portfolios and contribute to the UK's life sciences sector. ## Notice The Catapult Centres are a network of world-leading centres designed to transform the UK's capability for innovation in specific areas and help drive future economic growth. (https://catapult.org.uk/catapult-centres/). Our specific area is medicines discovery. Part-funded by Innovate UK, an agency of the UK government, we are an independent not-for-profit company. We bring together industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high-value products. MDC is a national facility connecting the UK community to accelerate innovative drug discovery. We provide unique scientific capabilities and act as a gateway to UK resources and expertise, supporting UK SMEs in developing new medicines discovery approaches. By validating new ways of discovering medicines and driving key talent and expertise across the sector, we will support the UK life sciences industry, SMEs and innovators to deliver growth for the UK economy and maintain the UK's heritage position as a global leader in medicines R&D. MDC is currently in year 4 of our first 5-year grant funding agreement, referred to (GFA 1). To support our GFA1 evaluation, we have a logic model outlining our theory of change, and a supporting evaluation methodology framework, which we are in the process of implementing. In parallel to the work we are delivering for GFA 1, Innovate UK has asked that we develop our logic model and evaluation methodology framework to support our next grant funding agreement, GFA 2. The estimated value is between PS20,000.00 and PS35,000.00. Link to ITT documents here: https://procontract.due-north.com/RFx/RFxSummary?rfxId=2fb9a540-c5d8-eb11-810c-005056b64545 ### Lot Information Lot 1 The Catapult Centres are a network of world-leading centres designed to transform the UK's capability for innovation in specific areas and help drive future economic growth. (https://catapult.org.uk/catapult-centres/). Our specific area is medicines discovery. Part-funded by Innovate UK, an agency of the UK government, we are an independent not-for-profit company. We bring together industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high-value products. MDC is a national facility connecting the UK community to accelerate innovative drug discovery. We provide unique scientific capabilities and act as a gateway to UK resources and expertise, supporting UK SMEs in developing new medicines discovery approaches. By validating new ways of discovering medicines and driving key talent and expertise across the sector, we will support the UK life sciences industry, SMEs and innovators to deliver growth for the UK economy and maintain the UK's heritage position as a global leader in medicines R&D. MDC is currently in year 4 of our first 5-year grant funding agreement, referred to (GFA 1). To support our GFA1 evaluation, we have a logic model outlining our theory of change, and a supporting evaluation methodology framework, which we are in the process of implementing. In parallel to the work we are delivering for GFA 1, Innovate UK has asked that we develop our logic model and evaluation methodology framework to support our next grant funding agreement, GFA 2. The estimated value is between PS20,000.00 and PS35,000.00. Link to ITT documents here: https://procontract.due-north.com/RFx/RFxSummary?rfxId=2fb9a540-c5d8-eb11-810c-005056b64545 ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/014806-2021 | | Notice type | Tender Notice | | Procurement type | Standard | | Procurement category | Services | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Not specified | | All stages | Tender | ## Dates | Field | Value | | --- | --- | | Publication date | 29 Jun 2021 | | Submission deadline | 9 Jul 2021 | | Future notice date | Not specified | | Award date | Not specified | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | Not specified | | Lots value | £35,000 | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Active | | Lots status | Active | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | MEDICINES DISCOVERY CATAPULT | | Locality | CHESHIRE | | Post town | Stockport | | Postcode | SK10 4TG | | Country | England | | ITL 1 | TLD North West (England) | | ITL 2 | TLD6 Cheshire | | ITL 3 | TLD62 Cheshire East | | Local authority | Cheshire East | | Electoral ward | Chelford | | Westminster constituency | Tatton | | Delivery location | TLD62 Cheshire East | ## CPV Codes ### Divisions - 79 - Business services: law, marketing, consulting, recruitment, printing and security ### Codes - 79000000 - Business services: law, marketing, consulting, recruitment, printing and security ## Release History - 29 Jun 2021 at 10:59 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/014806-2021 ## Notice URLs - https://catapult.org.uk/catapult-centres/ - https://md.catapult.org.uk/ - https://procontract.due-north.com/RFx/RFxSummary?rfxId=2fb9a540-c5d8-eb11-810c-005056b64545 ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02c149. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-02c149.json.